Substrate Reduction Therapy Reverses Mitochondrial, mTOR, and Autophagy Alterations in a Cell Model of Gaucher Disease

Substrate reduction therapy (SRT) in clinic adequately manages the visceral manifestations in Gaucher disease (GD) but has no direct effect on brain disease. To understand the molecular basis of SRT in GD treatment, we evaluated the efficacy and underlying mechanism of SRT in an immortalized neurona...

Descripción completa

Detalles Bibliográficos
Autores principales: Peng, Yanyan, Liou, Benjamin, Lin, Yi, Fannin, Venette, Zhang, Wujuan, Feldman, Ricardo A., Setchell, Kenneth D. R., Grabowski, Gregory A., Sun, Ying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8466461/
https://www.ncbi.nlm.nih.gov/pubmed/34571934
http://dx.doi.org/10.3390/cells10092286

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8466461/
https://www.ncbi.nlm.nih.gov/pubmed/34571934
http://dx.doi.org/10.3390/cells10092286

Ejemplares similares